Cellectis S.A.
CLLS
$2.90
$0.082.84%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 68.07M | 72.95M | 75.27M | 56.30M | 47.63M |
| Total Other Revenue | 7.04M | 6.65M | 7.28M | 7.14M | 7.12M |
| Total Revenue | 75.11M | 79.59M | 82.55M | 63.44M | 54.75M |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 75.11M | 79.59M | 82.55M | 63.44M | 54.75M |
| SG&A Expenses | 20.68M | 19.79M | 19.92M | 19.88M | 18.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -275.00K | -638.00K | -911.00K | -932.00K | -1.24M |
| Total Operating Expenses | 119.18M | 112.67M | 108.96M | 108.65M | 107.59M |
| Operating Income | -44.06M | -33.08M | -26.40M | -45.22M | -52.84M |
| Income Before Tax | -67.61M | -68.02M | -34.84M | -58.54M | -60.27M |
| Income Tax Expenses | -377.00K | -423.00K | 514.00K | 455.00K | 262.00K |
| Earnings from Continuing Operations | -67.23 | -67.59 | -35.35 | -59.00 | -60.53 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -67.23M | -67.59M | -35.35M | -59.00M | -60.53M |
| EBIT | -44.06M | -33.08M | -26.40M | -45.22M | -52.84M |
| EBITDA | -32.75M | -21.75M | -13.87M | -33.04M | -41.05M |
| EPS Basic | -0.67 | -0.68 | -0.36 | -0.59 | -0.63 |
| Normalized Basic EPS | -0.42 | -0.43 | -0.13 | -0.28 | -0.30 |
| EPS Diluted | -0.67 | -0.68 | -0.36 | -0.59 | -0.63 |
| Normalized Diluted EPS | -0.42 | -0.43 | -0.13 | -0.28 | -0.30 |
| Average Basic Shares Outstanding | 400.08M | 399.71M | 399.48M | 399.24M | 390.59M |
| Average Diluted Shares Outstanding | 401.46M | 401.09M | 400.86M | 399.24M | 390.59M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |